Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Miragen Therapeutics Inc (NASDAQ:MGEN)

9.42
Delayed Data
As of Oct 20
 +0.44 / +4.90%
Today’s Change
1.80
Today|||52-Week Range
18.00
+88.02%
Year-to-Date
No recent news for Miragen Therapeutics Inc.

Today’s Trading

Previous close8.98
Today’s open9.10
Day’s range8.90 - 9.52
Volume232,402
Average volume (3 months)86,392
Market cap$202.4M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+16.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales1.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOMXFoamix Pharmaceutica...+0.31+4.76%
NYMXNymox Pharmaceutical...+0.01+0.26%
CKPTCheckpoint Therapeut...-0.40-6.02%
MNOVMediciNova Inc-0.05-0.81%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 17, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$3.3M
Annual profit (last year)-$12.7M
Net profit margin-379.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William S. Marshall
Chief Financial Officer, Secretary &
Treasurer
Jason A. Leverone
Corporate headquarters
Boulder, Colorado

Forecasts